
Quarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Market Cap 2011-2026 | CSII
As of February 06, 2026 Cardiovascular Systems has a market cap of $ 844 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 588 M | 815 M | 1.41 B | 1.54 B | 1.11 B | 1.03 B | 638 M | 943 M | 809 M | 427 M | 167 M | 238 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.54 B | 167 M | 810 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 7.25 | -8.17 % | $ 521 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.97 | - | $ 137 M | ||
|
Alphatec Holdings
ATEC
|
1.55 B | $ 13.48 | -4.13 % | $ 1.93 B | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 4.08 | 0.37 % | $ 152 M | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 299.07 | -2.23 % | $ 8.44 B | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 41.06 | -3.54 % | $ 6.12 K | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
155 B | $ 78.26 | 3.65 % | $ 115 B | ||
|
Abbott Laboratories
ABT
|
235 B | $ 109.11 | 0.84 % | $ 190 B | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
466 M | $ 12.43 | -6.61 % | $ 336 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
1.94 B | $ 40.63 | 1.75 % | $ 1.25 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
175 M | $ 28.95 | -0.96 % | $ 245 M | ||
|
InMode Ltd.
INMD
|
1.43 B | $ 14.77 | -1.66 % | $ 1.17 B | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
230 M | $ 6.35 | -6.89 % | $ 180 M | ||
|
Align Technology
ALGN
|
13.9 B | $ 176.77 | 9.59 % | $ 13.2 B | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 18.54 | 0.11 % | $ 122 M | ||
|
Globus Medical
GMED
|
11.4 B | $ 87.55 | 0.56 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 10.94 | -1.26 % | $ 842 M | ||
|
Establishment Labs Holdings
ESTA
|
1.2 B | $ 66.7 | -3.52 % | $ 1.88 B | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.45 | 0.69 % | $ 23.4 M | ||
|
IRadimed Corporation
IRMD
|
670 M | $ 94.23 | 0.4 % | $ 1.19 B | ||
|
Integer Holdings Corporation
ITGR
|
4.58 B | $ 85.94 | 0.49 % | $ 2.89 B | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.67 | 0.3 % | $ 36.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
589 M | $ 16.64 | -1.54 % | $ 384 M |